Chronic Kidney Disease News

Use of SGLT2 inhibitors was associated with improved kidney health among a diverse multiethnic cohort of Asian adults with type 2 diabetes, researchers found in a retrospective cohort study.

Heat exposure may be linked to increased risk for hyponatremia for older adults, particularly women, according to results of a cross-sectional study of hospitalized adults.

Patients’ smoking behaviors may be associated with elevated risks for chronic kidney disease, but more data are needed, according to researchers.

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease, congestive heart failure, CVD and overall mortality.

Registered dietitian nutritionists caring for patients with chronic kidney disease are frequently challenged to help address multiple chronic diseases, comorbidities and acute issues to achieve goals for health and well-being.

Obesity is an important health issue for patients with chronic kidney disease, speeding its progression, contributing to disability and limiting access to organ transplantation. Up to now, nephrologists typically do not manage obesity.

For the second time since 2019, the oral SGLT1 and SGLT2 dual inhibitor sotagliflozin has been denied FDA approval for adults with type 1 diabetes, with elevated risk for diabetic ketoacidosis being a primary concern.

Higher urinary arsenic levels were associated with kidney damage among U.S. adults in a study that assessed data from the National Health and Nutrition Examination Survey.

The National Kidney Foundation published a consensus document that advocates transition to race-free eGFR equations in health-related decision-making.